Table 2

Descriptive summary of secondary outcomes by trial arm and time and pairwise comparison output

TimeTrial armPairwise comparisons
GroupIndividualUCGroup–UCIndividual–UCIndividual–group
LDL cholesterol (mmol/mol)Baseline3.11 (0.85)3.14 (0.89)3.07 (0.88)
12 months2.93 (0.85)2.92 (0.83)2.91 (0.87)0 (−0.07 to 0.07)0 (−0.07 to 0.08)0 (−0.07 to 0.08)
24 months3.04 (0.90)3.02 (0.88)2.94 (0.90)0.07 (−0.01 to 0.15)0.05 (−0.04 to 0.14)−0.02 (−0.10 to 0.07)
QRisk2 score
(%)
Baseline24.95 (4.79)25.26 (5.27)24.93 (4.81)
12 months25.18 (5.60)25.54 (5.93)25.50 (6.04)−0.28 (−0.79 to 0.23)−0.14 (−0.68 to 0.40)0.14 (−0.36 to 0.64)
24 months26.73 (7.12)27.04 (6.59)26.69 (6.76)0.01 (−0.68 to 0.71)0.05 (−0.63 to 0.72)0.03 (−0.64 to 0.71)
  • Cell values are mean (SD) or estimate (95% CI).

  • LDL, low-density lipoprotein; UC, usual care.